PureTech notes positive results from Shionogi's EndeavorRx ADHD trial | Finance News shareprices.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from shareprices.com Daily Mail and Mail on Sunday newspapers.
PureTech-Founded (PRTC) Akili (AKLI) Reports Positive Results from Shionogi's Phase 3 Clinical Trial of Localized Version of Akili's EndeavorRx streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
PureTech Health PLC on Tuesday noted that its founded entity, Akili Inc, has announced positive results from a phase 3 clinical trial of EndeavorRx for children with attention deficit hyperactivity.
Form PRE 14A Akili, Inc. For: Apr 17 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Akili (NASDAQ:AKLI – Get Free Report) will be posting its quarterly earnings results after the market closes on Thursday, February 29th. Analysts expect Akili to post earnings of ($0.26) per share for the quarter. Akili Stock Performance Shares of AKLI stock traded up $0.00 during mid-day trading on Thursday, reaching $0.22. 153,834 shares of the […]